....don't sell into the panic. It's horrible that AGENDA didn't produce the results we wanted, but Tesetaxel is still in late stage clinical trials and has the chance to be a blockbuster.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.